On Cancer: Clinical Research

Share
Print
and/or
165 Blog posts found

In the Clinic

Back-to-Back Studies Support the Use of HER2-Targeted Therapies in Multiple Cancers

Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.

The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti

In the Clinic

Liquid Biopsy Can Guide Treatment for Women with Metastatic Breast Cancer

By identifying mutations found in a person’s cancer, this blood test can help doctors tailor treatments to those most likely to benefit.

blood tube laying atop DNA sequence

In the Clinic

What’s the Best Way to Screen for Breast Cancer? Abbreviated MRI Beats 3-D Mammography, but Research Is Ongoing

Experts at MSK are exploring more-advanced screening techniques with the goal of detecting breast cancer earlier.

A woman receives a mammogram, and two technicians help her.

Feature

A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.

A female nurse talks with a female patient, who is sitting in an exam chair

Feature

For People with a Rare Mouth Cancer, a Targeted Drug Can Be Lifesaving

The drug targets a protein called HER2 found on some salivary gland tumors.

Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.

In the News

Year in Review: 10 Important Clinical Research Discoveries in 2019

As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.

Memorial Sloan Kettering medical oncologist Eileen O’Reilly

In the Clinic

Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.

Illustration of breast cancer cell

Finding

Many Mutations Detected in Liquid Biopsy Tests Do Not Come from Cancer Cells, an MSK Study Finds

The new findings suggest the need for caution when interpreting the results from these tests.

Pedram Razavi, Jorge Reis-Filho, and Bob Li

Q&A

Meet Julia Glade Bender, Who’s Focused on Developing Better Treatments for Kids with Cancer

Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.

Pediatric oncologist Julia Glade Bender